Bakır(II) iyonunun 5,7-dihidroksiflavon ve sübstitue 2,2’-bipiridin ile yeni bir karışık ligand kompleksi

Abstract

Bu çalışmada 5,7-dihidroksiflavon (chrysin, chr) ve 4,4′-di-ter-bütil-2,2′-bipiridin (4,4’-dtbbpy) ligandları kullanılarak Cu(II) iyonunun yeni bir karışık ligand-bakır(II) koordinasyon bileşiği elde edildi. Sentezlenen bu koordinasyon bileşiğinin yapısı, elementel analiz, iletkenlik, manyetik süsseptibilite, kütle spektrometrisi ve Infrared (IR) spektroskopisi yöntemleriyle aydınlatıldı. Ayrıca TGA/DSC analizi ile yapısı desteklendi ve termal özellikleri araştırıldı. Elde edilen analiz verilerinden sentezlenen bileşikte, Cu(II) iyonu:chr-H:4,4’-dtbbpy oranının 1:1:1 olduğu ve koordinasyon küresi içerisinde ClO4- iyonunun bulunduğu nötral bir kompleks elde edildiği saptandı. Sonuç olarak sentezlenen koordinasyon bileşiği için [Cu(chr-H)(ClO4)(4,4’-dtbbpy)] formülü önerildi.

Keywords

• Karışık ligand-Cu(II) kompleksi
• 5,7-dihidroksiflavon
• 4,4′-di-ter-bütil-2,2′-bipiridin

Supporting Institution

Bursa Uludağ Üniversitesi Bilimsel Araştırma Projeleri Koordinasyon Birimi

Project Number

FHIZ-2021-440

Thanks

Bu çalışma Bursa Uludağ Üniversitesi Bilimsel Araştırma Projeleri Koordinasyon Birimine bağlı yürütülen FHIZ-2021-440 Nolu proje ile desteklenmiştir. Desteklerinden dolayı Bursa Uludağ Üniversitesi Bilimsel Araştırma Projeleri Birimi’ne teşekkürlerimi sunarım.

A new mixed ligand complex of copper(II) Ion with 5,7-dihydroxyflavone and substituted 2,2'-bipyridine

Abstract

In this study, a new mixed ligand-copper(II) coordination compound of Cu(II) ion was obtained by using 5,7-dihydroxyflavone (chrysin, chr) and 4,4′-di-tert-butyl-2,2′-bipyridine (4,4’-dtbbpy) ligands. The structure of this synthesized coordination compound was elucidated by elemental analysis, conductivity, magnetic susceptibility, mass spectrometry and Infrared (IR) spectroscopy methods. In addition, its structure was supported by TGA/DSC analysis and its thermal properties were investigated. From the analysis data obtained, in the synthesized compound it was determined that the ratio of Cu(II) ion:chr-H: 4,4’-dtbbpy was 1:1:1 and a neutral complex was obtained with ClO4- ion in the coordination sphere. As a result, the formula [Cu(chr-H)(ClO4)(4,4'-dtbbpy)] was proposed for the synthesized coordination compound.

Keywords

• Mixed ligand-Cu(II) complex
• 5,7-dihydroxyflavone
• 4,4′-di-tert-butyl-2,2′-bipyridine

Project Number

FHIZ-2021-440

References

1. Coşkun, P. ve İnci, H., Propolisin kimyasal içeriği ile antibakteriyel, antiviral ve antioksidan aktivitesi, ISPEC Journal of Agricultural Sciences, 4, 4, 1053-1070, (2020).
2. Pietta, P.G., Flavonoids as Antioxidants, Journal of Natural Products, 63, 7, 1035–1042, (2000).
3. Wang, L., Tu, Y.C., Lian, T.W., Hung, J.T., Yen, J.H. ve Wu, M.J., Distinctive antioxidant and anti-inflammatory effects of flavonols, Journal of Agricultural and Food Chemistry, 54, 26, 9798–9804, (2006).
4. Kopustinskiene, D.M., Jakstas, V., Savickas, A. ve Bernatoniene, J., Flavonoids as Anticancer Agents, Nutrients, 12, 2, 457, (2020).
5. García-Lafuente, A., Guillamón, E., Villares, A., Rostagno, M.A. ve Martínez J.A., Flavonoids as antiinflammatory agents: implications in cancer and cardiovascular disease, Inflammation Research, 58, 537–552, (2009).
6. Lalani, S. ve Poh, C.L., Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71), Viruses, 12, 2, 184, (2020).
7. Cheong, H., Ryu, S.Y., Oak, M.H., Cheon, S.H., Yoo, G.S. ve Kim, K.M., Studies of structure activity relationship of flavonoids for the anti-allergic actions, Archives of Pharmacal Research, 21, 4, 478-480, (1998).
8. Gryglewski, R.J., Korbut, R., Robak, J. ve Świȩs, J., On the mechanism of antithrombotic action of flavonoids, Biochemical Pharmacology, 36, 3, 317-322, (1987).

9. Górniak, I., Bartoszewski, R. ve Króliczewski, J., Comprehensive review of antimicrobial activities of plant flavonoids, Phytochemistry Reviews, 18, 241–272, (2019).
10. Islas, M.S., Naso L.G., Lezama, L., Valcarcel, M., Salado, C., Roura-Ferrer, M., Ferrer, E.G. ve Williams, P.A.M., Insights into the mechanisms underlying the antitumor activity of an oxidovanadium(IV) compound with the antioxidant naringenin. Albumin binding studies, Journal of Inorganic Biochemistry, 149, 12-24, (2015).
11. Spoerlein, C., Mahal, K., Schmidt, H. ve Schobert, R., Effects of chrysin, apigenin, genistein and their homoleptic copper (II) complexes on the growth and metastatic potential of cancer cells, Journal of Inorganic Biochemistry, 127, 107-115, (2013).
12. Tamayo, L.V., Gouvea, L.R., Sousa, A.C., Albuquerque, R.M., Teixeira S.F., de Azevedo R.A., Louro, S.R.W., Ferreira A.K. ve Beraldo, H., Copper(II) complexes with naringenin and hesperetin: cytotoxic activity against A 549 human lung adenocarcinoma cells and investigation on the mode of action, Biometals, 29, 39-52, (2016).
13. Filho, J.C.C., Sarria, A.L.F., Becceneri, A.B., Fuzer, A.M., Batalhão, J.R., da Silva, C.M.P., Carlos, R.M., Vieira, P.C., Fernandes, J.B. ve Cominetti, M.R., Copper(II) and 2,2’-Bipyridine Complexation Improves Chemopreventive Effect of Naringenin against Breast Tumor Cells, PLOS ONE, 9, 9, e107058, (2014).
14. Mutlu Gençkal, H., Erkisa, M., Alper, P., Sahin, S., Ulukaya, E. ve Ari, F., Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: synthesis, characterization, anti cancer and anti oxidant activity. Journal of Biological Inorganic Chemistry, 25, 161–177, (2020).
15. Mani, R., ve Natesan, V., Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry, 145, 187-196, (2018).
16. Shoosshtari, M.K., Sarkaki, A., Mansouri, S.M.T., Badavi, M., Khorsandi, L., Dehcheshmeh, M.G. ve Farbood , Y., Protective effects of Chrysin against memory impairment, cerebral hyperemia and oxidative stress after cerebral hypoperfusion and reperfusion in rats, Metabolic Brain Disease, 35, 401–412, (2020).
17. Hea, X.-L., Wang, Y.-H., Bi, M.-G. ve Du, G.-H., Chrysin improves cognitive deficits and brain damage induced by chronic cerebral hypoperfusion in rats, European Journal of Pharmacology, 680, 1-3, 41–48, (2012).
18. Shoieb, S.M., Esmat, A., Khalifa, A.E. ve Abdel-Naim, A.B., Chrysin attenuates testosterone-induced benign prostate hyperplasia in rats, Food and Chemical Toxicology, 111, 650-659, (2018).
19. Mutlu Gençkal, H., New heteroleptic Cu(II) complexes of chrysin with 2,2ꞌ–bipyridine and substituted 1,10–phenanthrolines: Synthesis, characterization, thermal stability and antioxidant activity, Journal of Molecular Structure, 1209, 127917, (2020).
20. Geary, W.J., The use of conductivity measurements in organic solvents for the characterisation of coordination compounds, Coordination Chemistry Reviews, 7, 1, 81-122, (1971).
21. Vishwakarma, P.K., Mir J.M. ve Maurya, R.C., Pyrone-based Cu(II) complexes, their characterization, DFT based conformational drift from square planar to square pyramidal geometry and biological activities, Journal of Chemical Sciences, 128, 4, 511–522, (2016).
22. Amani, V., Safari, N. ve Khavasi, H.R., Synthesis, characterization and crystal structure determination of iron(III) hetero-ligand complexes containing 2,2’-bipyridine, 5,5’-dimethyl-2,2’-bipyridine and chloride, [Fe(bipy)Cl4][bipyH] and [Fe(dmbipy)2Cl2][FeCl4], Polyhedron, 26, 15, 4257–4262, (2007).
23. Kaushal, R., Kumar, N., Awasthi, P. ve Nehra K., Syntheses, characterization, and antibacterial study of titanium complexes, Turkish Journal of Chemistry, 37, 6, 936-945, (2013).
24. Yilmaz, İ., Synthesis, structural characterization, and thermal properties of octahedral diperchlorato complexes of copper(II) with the chelating 2-aminomethylpiperidine and 2-aminomethylpyridine ligands, Inorganic and Nano-Metal Chemistry, 53, 4, 333-339, (2023).
25. Pusz, J. ve Nitka, B., Synthesis and physicochemical properties of the complexes of Co (II), Ni (II), and Cu (II) with chrysin, Microchemical Journal, 56, 3, 373-381, (1997).
26. Halevas, E., Mitrakas, A., Mavroidi, B., Athanasiou, D., Gkika, P., Antoniou, K., Samaras, G., Lialiaris, E., Hatzidimitriou, A., Pantazaki, A., Koukourakis, M., Sagnou, M., Pelecanou, M. ve Lialiaris, T., Structurally characterized copper-chrysin complexes display genotoxic and cytotoxic activity in human cells, Inorganica Chimica Acta, 515, 120062, (2021).
27. Roy, S., Sil, A. ve Chakraborty, T., Potentiating apoptosis and modulation of p53, Bcl2, and Bax by a novel chrysin ruthenium complex for effective chemotherapeutic efficacy against breast cancer, Journal of Cellular Physiology, 234, 4, 4888–4909, (2019).
28. Dalal, A., Nehra, K., Hooda, A., Singh, D., Kumar, S. ve Malik, R.S., Synthesis, photophysical characteristics and geometry optimization of Tris(2-benzoylacetophenonate)europium complexes with 2,2′-Bipyridine derivatives, Journal of Luminescence, 247, 118873, (2022).